We give you a written timeline estimate for your case before you commit.Ask about treatment
Guillain-Barre syndrome (GBS): what it is, how it is treated and how we can help families in the Gulf
A plain guide for families in the Gulf, checked against US FDA labels, US National Institutes of Health information, Gulf drug registers and published research on 17 October 2026.
Reviewed by the Reserve Meds clinical operations team on 17 October 2026.
Guillain-Barre syndrome: the short answer
There is no cure for GBS. Your specialist and hospital lead care. If they prescribe a US-approved medicine that is not available locally, the hospital can ask the national regulator to import it for one named patient. Reserve Meds is a digital health company that helps with that process. We do not diagnose or prescribe.
- US-approved medicine for this condition: none found in our label search on 17 October 2026.
- How we help: access to US-approved medicines your specialist prescribes, through the hospital.
- Price: Quote on request.
What is Guillain-Barre syndrome?
Guillain-Barre syndrome (GBS) is a rare neurological disorder in which the immune system mistakenly attacks part of the peripheral nervous system, the network of nerves that carries signals from the brain and spinal cord to the rest of the body.[1]
GBS begins suddenly and can increase over hours, days or weeks. Some cases are mild, with brief weakness. Others cause severe paralysis, so the person cannot breathe on their own, which is life-threatening. Most people reach their weakest point within the first two weeks, and by the third week 90% of affected people are at their weakest.[1]
Most people eventually recover, even from severe cases, although some weakness may remain. One of the most common risk factors is infection with Campylobacter jejuni, which causes gastroenteritis.[1]
Guillain-Barre syndrome in the Gulf
Gulf neurologists have reported cases related to GBS, including a 2025 case series in The Lancet Neurology of acute-onset axonal neuropathy after infection in children with RCC1 variants, and a 2016 review of neurological complications of bariatric surgery in Neurosciences (Riyadh).[2, 3]
Treatment and US-approved medicines
There is no cure for GBS. Two hospital treatments are commonly used to interrupt immune-related nerve damage, plasma exchange and immunoglobulin therapy, and both work equally well if started within two weeks of symptoms. In our search of current US drug labels on 17 October 2026, we did not find a medicine whose US label lists GBS as an approved use. Treatment is given in hospital by the neurology team.[1]
How families in the Gulf can access treatment
If it is not registered. The usual legal route is a named-patient request: the treating hospital, on your specialist's written request, asks the national regulator for permission to import the medicine for one patient, using the US FDA approval as the reference. In Saudi Arabia the SFDA Special Access Program guidance covers these requests; in Bahrain, NHRA Circular 41 of 2020 sets the procedure. Other Gulf countries have their own procedures, which the hospital confirms.[4, 5] Once approval is in place, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital.
Who does what
- Your treating specialist decides whether a medicine is right for the patient and writes the medical letter.
- The hospital checks local supply, files any import request, and gives the treatment safely.
- The national regulator decides whether to approve the import of a medicine that is not registered.
- The manufacturer decides where its medicine can be supplied, especially for cell and gene therapies.
- Reserve Meds helps organize records, coordinates US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.
Documents you will usually need
- A letter from the treating specialist with the diagnosis, past treatments and why this medicine is being considered
- Reports that confirm the diagnosis, such as genetic, pathology, imaging or laboratory results, translated into English where needed
- Recent clinic notes and a list of current medicines
- For a hospital import request: the prescription, the hospital's request form and the written consent of the patient or guardian
- Proof of the US FDA approval and the US prescribing information (we can supply these)
We give you a written timeline estimate for your case before you commit. The regulator, the hospital or treatment center and the manufacturer set their own timelines.
What treatment costs
Quote on request. Your total cost depends on the medicine, the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.
How Reserve Meds helps
Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and temperature-controlled shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them.
Ask us about treatment for Guillain-Barre syndrome
Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.
Frequently asked questions
Is there an FDA-approved medicine for Guillain-Barre syndrome?
There is no cure for GBS. Two hospital treatments are commonly used to interrupt immune-related nerve damage, plasma exchange and immunoglobulin therapy, and both work equally well if started within two weeks of symptoms. In our search of current US drug labels on 17 October 2026, we did not find a medicine whose US label lists GBS as an approved use. Treatment is given in hospital by the neurology team.
What can Reserve Meds do if there is no approved medicine?
We can explain the options your specialist raises. If they prescribe a US-approved medicine for your case that is not available locally, we help the hospital with the import process. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them.
Does Reserve Meds diagnose or prescribe?
No. Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We do not diagnose, prescribe or decide what a regulator approves. Your specialist and hospital make the medical decisions.
Is GBS the same as CIDP?
No. GBS comes on over days to weeks and then usually improves. CIDP is long-lasting and can relapse, and it has US-approved medicines. See our CIDP page.
Sources for the condition-specific answers: [1, 6]
Sources
Accessed and checked on 17 October 2026. Labels, registers and regulator rules change. Your hospital confirms the current position before anything is filed.
- National Institute of Neurological Disorders and Stroke (NINDS): Guillain-Barré Syndrome
- Harkness JR, et al. Acute-onset axonal neuropathy following infection in children with biallelic RCC1 variants: a case series. Lancet Neurol. 2025 (PubMed 40683276)
- Algahtani HA, et al. Neurological complications of bariatric surgery. Neurosciences (Riyadh). 2016 (PubMed 27356656)
- SFDA: Special Access Program (SAP) guidance, version 1.0
- NHRA Bahrain: Circular No. (41) of 2020, procedures for importing non-registered medicines and pharmaceutical products
- NORD (National Organization for Rare Disorders): Chronic Inflammatory Demyelinating Polyneuropathy
Related
- CIDP
- Autoimmune encephalitis
- Multiple sclerosis
- Named-patient access in the Gulf, explained
- US-approved medicines not yet registered in the Gulf
- Answers to common access questions
- Cross-border disclosures
- اقرأ هذه الصفحة بالعربية
This page is general health information, not medical advice. It does not replace a consultation with your doctor.